U.S. FDA Approves SECUADO® (asenapine) Transdermal System, the First-and-Only Transdermal Patch for the Treatment of Adults with Schizophrenia - Business Wire

U.S. FDA Approves SECUADO® (asenapine) Transdermal System, the First-and-Only Transdermal Patch for the Treatment of Adults with Schizophrenia  Business Wire

Comments

Popular Posts

Diabetic vascular diseases: molecular mechanisms and therapeutic strategies

Effects of hot weather, humidity on blood pressure, heart

Atherosclerosis common in adults without heart disease, symptoms